438 related articles for article (PubMed ID: 18647272)
1. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
Sümpelmann R; Kretz FJ; Gäbler R; Luntzer R; Baroncini S; Osterkorn D; Haeger MC; Osthaus WA
Paediatr Anaesth; 2008 Oct; 18(10):929-33. PubMed ID: 18647272
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS).
Sümpelmann R; Kretz FJ; Luntzer R; de Leeuw TG; Mixa V; Gäbler R; Eich C; Hollmann MW; Osthaus WA
Paediatr Anaesth; 2012 Apr; 22(4):371-8. PubMed ID: 22211931
[TBL] [Abstract][Full Text] [Related]
3. Changes in acid-base, electrolyte and hemoglobin concentrations during infusion of hydroxyethyl starch 130/0.42/6 : 1 in normal saline or in balanced electrolyte solution in children.
Sümpelmann R; Witt L; Brütt M; Osterkorn D; Koppert W; Osthaus WA
Paediatr Anaesth; 2010 Jan; 20(1):100-4. PubMed ID: 19968805
[TBL] [Abstract][Full Text] [Related]
4. Alteration of anion gap and strong ion difference caused by hydroxyethyl starch 6% (130/0.42) and gelatin 4% in children.
Witt L; Osthaus WA; Jüttner B; Heimbucher C; Sümpelmann R
Paediatr Anaesth; 2008 Oct; 18(10):934-9. PubMed ID: 18811828
[TBL] [Abstract][Full Text] [Related]
5. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
6. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients.
Ertmer C; Wulf H; Van Aken H; Friederich P; Mahl C; Bepperling F; Westphal M; Gogarten W
Minerva Med; 2012 Apr; 103(2):111-22. PubMed ID: 22513516
[TBL] [Abstract][Full Text] [Related]
8. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery.
Boldt J; Schöllhorn T; Münchbach J; Pabsdorf M
Eur J Anaesthesiol; 2007 Mar; 24(3):267-75. PubMed ID: 17054812
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of volume substitutes 5 percent human albumin and 6 percent hydroxyethyl starch (40,000/0.5) in pediatric anesthesia].
Hausdörfer J; Hagemann H; Heine J
Anasth Intensivther Notfallmed; 1986 Jun; 21(3):137-42. PubMed ID: 2428266
[TBL] [Abstract][Full Text] [Related]
10. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
12. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin.
Mukhtar A; Aboulfetouh F; Obayah G; Salah M; Emam M; Khater Y; Akram R; Hoballah A; Bahaa M; Elmeteini M; Hamza A
Anesth Analg; 2009 Sep; 109(3):924-30. PubMed ID: 19690268
[TBL] [Abstract][Full Text] [Related]
13. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.
Hanart C; Khalife M; De Villé A; Otte F; De Hert S; Van der Linden P
Crit Care Med; 2009 Feb; 37(2):696-701. PubMed ID: 19114887
[TBL] [Abstract][Full Text] [Related]
14. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
15. Lactated Ringer's solution versus hydroxyethyl starch for volume replacement in autologous blood donors with cardiovascular disease: a controlled, randomized trial.
Kasper SM; Dahlmann H; Mellinghoff H; Ellering J; Baumann M; Buzello W
Vox Sang; 1998; 75(1):26-31. PubMed ID: 9745150
[TBL] [Abstract][Full Text] [Related]
16. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of hydroxyethyl starch 6% 130/0.4 in a balanced electrolyte solution (Volulyte) during cardiac surgery.
Base EM; Standl T; Lassnigg A; Skhirtladze K; Jungheinrich C; Gayko D; Hiesmayr M
J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):407-14. PubMed ID: 21345699
[TBL] [Abstract][Full Text] [Related]
18. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
[TBL] [Abstract][Full Text] [Related]
19. A randomized prospective analysis of alteration of hemostatic function in patients receiving tranexamic acid and hydroxyethyl starch (130/0.4) undergoing off pump coronary artery bypass surgery.
Chakravarthy M; Muniraj G; Patil S; Suryaprakash S; Mitra S; Shivalingappa B
Ann Card Anaesth; 2012; 15(2):105-10. PubMed ID: 22508200
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
